Seguir
Robert Haddad, M.D.
Robert Haddad, M.D.
Professor, Dana Farber Cancer Institute, Harvard Medical School, McGraw Chair Head and Neck Oncology
Dirección de correo verificada de dfci.harvard.edu
Título
Citado por
Citado por
Año
Nivolumab for recurrent squamous-cell carcinoma of the head and neck
RL Ferris, G Blumenschein Jr, J Fayette, J Guigay, AD Colevas, L Licitra, ...
New England Journal of Medicine 375 (19), 1856-1867, 2016
45642016
Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer
MR Posner, DM Hershock, CR Blajman, E Mickiewicz, E Winquist, ...
New England Journal of Medicine 357 (17), 1705-1715, 2007
20562007
Recent advances in head and neck cancer
RI Haddad, DM Shin
New England Journal of Medicine 359 (11), 1143-1154, 2008
11322008
Antitumor activity of pembrolizumab in biomarker-unselected patients with recurrent and/or metastatic head and neck squamous cell carcinoma: results from the phase Ib KEYNOTE …
LQM Chow, R Haddad, S Gupta, A Mahipal, R Mehra, M Tahara, R Berger, ...
Journal of Clinical Oncology 34 (32), 3838, 2016
8512016
Head and neck cancers, version 2.2020, NCCN clinical practice guidelines in oncology
DG Pfister, S Spencer, D Adelstein, D Adkins, Y Anzai, DM Brizel, ...
Journal of the National Comprehensive Cancer Network 18 (7), 873-898, 2020
8022020
Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck …
R Haddad, A O'Neill, G Rabinowits, R Tishler, F Khuri, D Adkins, J Clark, ...
The Lancet Oncology 14 (3), 257-264, 2013
7572013
Nivolumab vs investigator’s choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by …
RL Ferris, G Blumenschein Jr, J Fayette, J Guigay, AD Colevas, L Licitra, ...
Oral oncology 81, 45-51, 2018
7282018
Head and neck cancers, version 2.2014
DG Pfister, S Spencer, DM Brizel, B Burtness, PM Busse, JJ Caudell, ...
Journal of the National Comprehensive Cancer Network 12 (10), 1454-1487, 2014
7262014
Pembrolizumab for platinum-and cetuximab-refractory head and neck cancer: results from a single-arm, phase II study
J Bauml, TY Seiwert, DG Pfister, F Worden, SV Liu, J Gilbert, NF Saba, ...
Journal of Clinical Oncology 35 (14), 1542, 2017
6452017
NCCN guidelines insights: head and neck cancers, version 1.2018
AD Colevas, SS Yom, DG Pfister, S Spencer, D Adelstein, D Adkins, ...
Journal of the National Comprehensive Cancer Network 16 (5), 479-490, 2018
5582018
Survival and human papillomavirus in oropharynx cancer in TAX 324: a subset analysis from an international phase III trial
MR Posner, JH Lorch, O Goloubeva, M Tan, LM Schumaker, NJ Sarlis, ...
Annals of oncology 22 (5), 1071-1077, 2011
5412011
Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: long-term results …
JH Lorch, O Goloubeva, RI Haddad, K Cullen, N Sarlis, R Tishler, M Tan, ...
The lancet oncology 12 (2), 153-159, 2011
4992011
Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumors
D Miao, CA Margolis, NI Vokes, D Liu, A Taylor-Weiner, SM Wankowicz, ...
Nature genetics 50 (9), 1271-1281, 2018
4962018
Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum …
JPH Machiels, RI Haddad, J Fayette, LF Licitra, M Tahara, JB Vermorken, ...
The Lancet Oncology 16 (5), 583-594, 2015
462*2015
Characterization of HPV and host genome interactions in primary head and neck cancers
M Parfenov, CS Pedamallu, N Gehlenborg, SS Freeman, L Danilova, ...
Proceedings of the National Academy of Sciences 111 (43), 15544-15549, 2014
4162014
Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related …
KJ Harrington, RL Ferris, G Blumenschein, AD Colevas, J Fayette, ...
The Lancet Oncology 18 (8), 1104-1115, 2017
4002017
Efficacy and safety of pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma: pooled analyses after long-term follow-up in KEYNOTE-012
R Mehra, TY Seiwert, S Gupta, J Weiss, I Gluck, JP Eder, B Burtness, ...
British journal of cancer 119 (2), 153-159, 2018
3962018
Head and neck cancer
MD Mody, JW Rocco, SS Yom, RI Haddad, NF Saba
The Lancet 398 (10318), 2289-2299, 2021
3762021
Response and acquired resistance to everolimus in anaplastic thyroid cancer
N Wagle, BC Grabiner, EM Van Allen, A Amin-Mansour, A Taylor-Weiner, ...
New England Journal of Medicine 371 (15), 1426-1433, 2014
3562014
Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised …
NY Lee, RL Ferris, A Psyrri, RI Haddad, M Tahara, J Bourhis, K Harrington, ...
The Lancet Oncology 22 (4), 450-462, 2021
3492021
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20